21 November 2022 | News
To reduce prevalence and improve health outcomes for patients diagnosed with cardiovascular and COPD/asthma disease in Alwar
Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of Mumbai-based pharma major Lupin has signed a Memorandum of Understanding (MoU) with the Government of Rajasthan to address the prevalence of Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disease (COPD) in the Alwar district of Rajasthan.
The MoU was signed in the presence of Dr K L Meena, Director Public Health, Department of Medical, Health and Family Welfare Government of Rajasthan and Tushara Shankar, Head – Corporate Social Responsibility, Lupin.
As per the MoU, LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes.
The collaboration will work towards serving the local communities in Alwar through preventive, curative and support-based solutions focused on curing the diseases in the short term and reducing their prevalence in the long term. The programme is planned to be rolled out in a phase-wise manner.
Non-communicable diseases (NCDs) contribute to nearly 5.87 million (60%) of all deaths in India. CVD and COPD are two leading causes but the prevalence rate of CVD and deaths due to COPD in Rajasthan both outpace national figures. Rajasthan is also among the most affected states in terms of respiratory disease.